摘要 |
<p>The present invention encompasses heterologous fusion proteins comprising a hyperglycsoylated G-CSF analog fusedto proteins such as albumin and the Fc portion of animmunoglobulin which act to extend the in vivo half-life ofthe protein compared to native G-CSF. These fusion proteinsare particularly suited for the treatment of conditions treatable by stimulation of circulating neutrophils, such as after chemotherapy regimens or in chronic congenitalneutropenia.</p> |